Identification | More | [Name]
BOC-HYP-OL | [CAS]
61478-26-0 | [Synonyms]
BOC-HYP-OL 61478-26-0 Boc-Hydroxyprolinol BOC-HYP-OL USP/EP/BP Boc-trans-4-hydroxy-L BOC-PRO(4-HYDROXY)-OL Boc-L-hydroxyprolinol (-)-N-BOC-L-4-HYDROXYPROLINOL BOC-TRANS-4-HYDROXY-L-PROLINOL (4R)-1-Boc-4-hydroxy-L-prolinol N-BOC-TRANS-4-HYDROXY-L-PROLINOL 1-BOC-TRANS-4-HYDROXY-L-PROLINOL N-T-BUTOXYCARBONYL-TRANS-4-HYDROXY-L-PROLINOL (2S,4R)-4-Hydroxy-2-(hydroxymethyl)pyrrolidine N-tert-Butoxycarbonyl-trans-4-hydroxy-L-prolinol (2S,4R)-1-BOC-4-HYDROXY-2-(HYDROXYMETHYL)PYRROLINE (2S,4R)-N-Boc-4-hydroxy-2-(hydroxymethyl)pyrrolidine (2S,4R)-1-Boc-4-hydroxy-2-(hydroxymethyl)pyrrolidine (2S,4R)-tert-butyl-4-hydroxy-2-(hydroxymethyl)carboxylat (2S,4R)-tert-butyl-4-hydroxy-2-(hydroxymethyl)carboxylate 1-Pyrrolidinecarboxylicacid, 4-hydroxy-2-(hydroxymethyl)- (2S,4R)-4-Hydroxy-2-(hydroxymethyl)pyrrolidine, N-BOC protected (2S,4R)-tert-butyl 4-hydroxy-2-(hydroxyMethyl)pyrrolidine-1-carb tert-Butyl 2-hydroxy-2-((2S,4R)-4-hydroxypyrrolidin-2-yl)acetate (2S,4R)-1-(tert-Butoxycarbonyl)-4-hydroxy-2-(hydroxyMethyl)pyrrolidine (2S,4R)-tert-butyl 4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate TERT-BUTYL (2S,4R)-4-HYDROXY-2-(HYDROXYMETHYL)PYRROLIDINE-1-CARBOXYLATE (2S,4R)-1-(tert-Butoxycarbonyl)-4-hydroxy-2-(hydroxymethyl)pyrrolidine > (2S,4R)-4-Hydroxy-2-hydroxymethyl-1-pyrrolidinecarboxylic acid tert-butyl ester 1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(hydroxymethyl)-, 1,1-dimethylethyl ester, (2S,4R)- trans-4-Hydroxy-L-prolinol, N-BOC protected, tert-Butyl (2S,4R)-4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate | [Molecular Formula]
C10H19NO4 | [MDL Number]
MFCD02094386 | [Molecular Weight]
217.26 | [MOL File]
61478-26-0.mol |
Chemical Properties | Back Directory | [Melting point ]
81-86 °C (lit.) | [alpha ]
-47o (C=1 IN CHLOROFORM) | [Boiling point ]
340.3±27.0 °C(Predicted) | [density ]
1.190±0.06 g/cm3(Predicted) | [storage temp. ]
Inert atmosphere,2-8°C | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
14.57±0.40(Predicted) | [color ]
White | [Optical Rotation]
[α]20/D 47°, c = 1 in chloroform | [Sensitive ]
Air Sensitive | [InChI]
InChI=1S/C10H19NO4/c1-10(2,3)15-9(14)11-5-8(13)4-7(11)6-12/h7-8,12-13H,4-6H2,1-3H3/t7-,8+/m0/s1 | [InChIKey]
UFJNFQNQLMGUTQ-JGVFFNPUSA-N | [SMILES]
N1(C(OC(C)(C)C)=O)C[C@H](O)C[C@H]1CO | [CAS DataBase Reference]
61478-26-0(CAS DataBase Reference) |
Hazard Information | Back Directory | [Chemical Properties]
Viscous Oil | [Uses]
BOC-HYP-OL is a useful reactant used in the preparation of 4-purinylpyrrolidine nucleosides, kinase inhibitors and antibacterial agents.
| [reaction suitability]
reaction type: Boc solid-phase peptide synthesis | [Synthesis]
Under argon protection, 1-tert-butyl 2-methyl-(2S,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate (5.0 g, 20.41 mmol) was dissolved in THF (100 mL), cooled to -16 °C and stirred. LiAlH4 (1 M solution of THF, 21 mL, 21 mmol) was added slowly and dropwise over 5 min and precipitate formation was observed in the reaction. THF (50 mL) was subsequently added to destroy the precipitate. The reaction mixture was gradually warmed to 0 °C with stirring for 3.5 hours. Upon completion of the reaction, the reaction was quenched with EtOAc (5 mL) and stirring was continued for 30 minutes. Then, an excess of Rochelle's salt solution (100 mL) was carefully added, and the mixture was warmed to room temperature and stirred for an additional 1 hour. The mixture was extracted twice with CH2Cl2 (100 mL), the organic phases were combined, dried with MgSO4, filtered and concentrated under reduced pressure to remove the solvent. The product was purified by column chromatography (eluent: 10% MeOH/CH2Cl2) to give Intermediate 19 in quantitative yield.1H NMR (300 MHz, DMSO-d6) δ: 4.82 (br s, 1H), 4.64 (br d, J = 5.5 Hz, 1H), 4.20 (sxt, J = 4.2 Hz, 1H), 3.75 (br s , 1H), 3.16-3.50 (m, 4H), 1.85-2.02 (m, 1H), 1.80 (br s, 1H), 1.39 (s, 9H). | [References]
[1] Patent: WO2017/29521, 2017, A1. Location in patent: Page/Page column 37 [2] Journal of Medicinal Chemistry, 1991, vol. 34, # 9, p. 2787 - 2797 [3] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 1, p. 56 - 60 [4] Patent: US2014/256016, 2014, A1. Location in patent: Paragraph 0024; 0025 [5] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1989, vol. 28, # 1-11, p. 294 - 296 |
|
|